XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 01, 2025
Sep. 18, 2025
Aug. 26, 2025
Aug. 13, 2025
Jun. 18, 2025
Feb. 20, 2025
Oct. 29, 2024
Nov. 06, 2025
Jun. 30, 2025
Apr. 30, 2025
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 26, 2025
Mar. 18, 2025
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Common stock, shares authorized                       2,000,000,000           2,000,000,000       2,000,000,000
Common stock, par value                       $ 0.086           $ 0.086       $ 0.086
Stock issued during the period value, acquisitions                           $ 239,425                
Stock issued during period value issued for services                       $ 100,000 $ 150,000 $ 141,750   $ 115,000            
Equity based compensation, shares                                   462,605        
Common stock, shares outstanding                       9,375,127           9,375,127       2,250,210
Value issued commission equity award expense                       151,236           151,236        
Share based compensation expense                       $ 2,740,796     $ 12,790     $ 4,593,149 $ 277,121      
Net proceed                                   2,136,526        
Agregate offering price                       (12,105)                    
Dividen per share                                       $ 0.03    
Dividends payable                       $ 373,986           $ 373,986      
At The Market Offering Program [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Number of shares available for issuance                       124,725           124,725        
Shares new issues 67,310                                          
Agregate offering price   $ 248,138   $ 2,026,453                                    
Gross proceeds commissions   3.00%                                        
Number of shares sold                       1,853,048           1,853,048        
Common shares issued for ATM share sales                       1,785,738                    
Number of shares net proceeds                       $ 2,021,682           $ 2,021,682        
Subsequent Event [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Dividends payable               $ 388,700                            
Shares issued               490,473                            
Subsequent Event [Member] | At The Market Offering Program [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Number of shares sold               $ 360                            
Number of shares sold               123,163                            
Number of shares net proceeds               $ 119,764                            
Series J Private Placement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Proceeds from issuance if private placement, gross         $ 2,500,000                                  
Agent fees.         351,000                                  
Net proceed         $ 2,150,000                                  
Cash fee percentage         7.00%                                  
Legal fees         $ 50,000                                  
Non-accountable expenses         $ 35,000                                  
Management fee percentage         1.00%                                  
2025 Equity Incentive Plan [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Share based compensation equity awards                 $ 2,495,000                          
Number of shares authorized for issuance                                         2,000,000  
Share based compensation equity awards, shares                 1,692,673                          
Number of shares available for issuance                       118,503           118,503     307,327  
Common Stock Purchase Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Shares new issues                                   450,000        
Agregate offering price     $ 10,000,000                             $ 350,000        
Common stock outstanding description     The agreement includes an Exchange Cap limiting issuances to 19.99% of the Company’s outstanding common stock as of the execution date unless stockholder approval is obtained or the average price paid for all shares issued equals or exceeds $0.9196, and a Beneficial Ownership Limitation preventing Investor from beneficially owning more than 4.99% (which may be increased to 9.99% upon 61 days’ prior written notice) of the Company’s outstanding common stock.                                      
Documentation fee                                   $ 10,000        
Common Stock Purchase Agreement [Member] | Subsequent Event [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Shares new issues               300,000                            
Agregate offering price               $ 300,000                            
Number of shares sold               $ 9,340,000                            
Common Stock Purchase Agreement [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Shares new issues                       53,186                    
Agregate offering price                       $ 50,000                    
Common Stock Purchase Agreement [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Forecast [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Agregate offering price                     $ 50,000                      
Directors Executives And Employees [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Share based compensation granted                           999,995                
Share based compensation equity awards                       $ 2,049,675   $ 2,049,675                
Share based compensation vested                       537,390           462,605        
Executive Officer [Member] | Employment Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Number of shares authorized for issuance                   40,000                        
Vesting period                   4 years                        
Number of shares vesting each year                   10,000   17,253           10,000        
Number of shares vesting fair value                                   $ 248,000        
Value issued commission equity award expense                                   7,253        
Unrecognized compensation cos                       $ 221,258           $ 221,258        
Investor [Member] | Common Stock Purchase Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Agregate offering price     $ 100,000                                      
Warrant Holders [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Dividends payable                       $ 92,000           $ 92,000        
Common Stock [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Stock issued during the period , acquisitions                           157,000                
Stock issued during the period value, acquisitions                           $ 13,502                
Stock issued during period shares issued for services                       110,668 123,967 105,000   17,825            
Stock issued during period value issued for services                       $ 9,518 $ 10,661 $ 9,064   $ 1,533            
Equity-based compensation, shares                       2,388,563 40 462,659 57,454 60,373 1,149          
Shares new issues           157,000 140,064         1,488,096                    
Agregate offering price                       $ 127,976                    
Common shares issued for ATM share sales                       1,785,738     247,418 302,677 11,036          
Series JPF Warrants [Member] | Series J Private Placement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Purchase of warrants         1,488,096                                  
Exercise price         $ 0.001                                  
Shares new issues                                   1,488,096        
Series J Warrants [Member] | Series J Private Placement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Purchase of warrants         2,976,192                                  
Exercise price         $ 1.43                                  
Warrant exercise price         $ 1.68                                  
Proceeds from issuance if private placement, gross         $ 4,250,000                                  
Warrants outstanding description         The Series J Warrants are exercisable from the date of issuance and expire two years from the Effective Date (as defined in the SPA-2025). The holder of the Series J-PF Warrants and the Series J Warrants may not exercise any portion of such holder’s Series J-PF Warrants or Series J Warrants to the extent that the holder, together with its affiliates, would beneficially own, respectively, more than 9.99% of 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of Common Stock immediately after exercise.                                  
Warrants term         2 years                                  
Series J PAW's Warrants [Member] | Series J Preferred Stock [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Exercise price         $ 2.10                                  
Series J PAW's Warrants [Member] | Series J Private Placement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Purchase of warrants         104,167